Cannabinoid Pathway Engineering

Cannabinoid pathway engineering refers to selective breeding and genetic selection aimed at modulating the enzymes and biochemical processes that synthesize cannabinoids like THC, CBD, and minor cannabinoids. Breeders working in this category isolate and stabilize plants expressing different ratios of cannabinoid synthase enzymes, which catalyze the final steps in cannabinoid production. Lineage records frequently report crosses designed to shift the CBDA/THCA ratio, suppress THC production in favor of CBD, or enhance minor cannabinoid expression such as CBG or CBC. This approach differs from traditional phenotype selection by targeting the underlying genetic regulators of the cannabinoid biosynthetic pathway. Understanding these mechanisms is foundational for breeding stable cultivars suited to specific regulatory, industrial, or research applications.

Breeders use pathway engineering data to predict cannabinoid profiles in offspring without extensive phenotypic screening, accelerate the stabilization of target ratios across generations, and develop cultivars with uncommon cannabinoid signatures for regulated markets or extraction workflows.